ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Genomic markers"

  • 2015 American Transplant Congress

    DNA Methylation Classifier Associates With Long-Term Graft Function Post-Kidney Transplantation

    J. Suh,1 D. Maluf, K. Archer,2 T. Lee,1 L. Gallon,3 V. Mas.1

    1UVA, Charlottesville, VA; 2VCU, Richmond, VA; 3Noerthwestern University, Chicago, IL.

    "Background. Late graft failure is a major problem after kidney transplantation (KT) mainly due to chronic renal allograft dysfunction (CRAD). Data about common pathways of…
  • 2015 American Transplant Congress

    Urinary Cell-Free DNA Is a Sensitive Marker of Early Renal Transplant Injury

    T. Sigdel, T. Tran, S.-C. Hsieh, M. Sarwal.

    Surgery, UC San Francisco, San Francisco, CA.

    Introduction:Circulating donor-derived cell-free DNA (dd-cfDNA) has been reported as a surrogate of transplant injury in the blood but requires expensive donor and recipient DNA sequencing.Method:…
  • 2015 American Transplant Congress

    Biomarker for Calcineurin Inhibitors Nephrotoxicity in Solid Organ Transplantation: Validation of a Urine Gene Expression Panel

    D. Maluf, R. Gehrau, J. Suh, K. Brayman, C. Bustamante, M. Edmunds, P. Darvishi, V. Mas.

    UVA, Charlottesville, VA.

    Background: We previously described a gene expression signature as biomarker of calcineurin inhibitor nephrotoxicity (CNIT) post renal transplantation. Herein, we aimed to validate the same…
  • 2015 American Transplant Congress

    Early Detection of HCC Mutations in Indeterminate Lesions Using Liquid Biopsies

    Y. Lin,1 K. Cavaness,2 Z. Zhang,1 S. Lin,3 K. Korenblat,1 G. Klintmalm,2 W. Chapman.1

    1Washington University, St. Louis, MO; 2Baylor University, Dallas, TX; 3Stanford University, Palo Alto, CA.

    Background Recent sequencing efforts have characterized the mutation profile of hepatocellular carcinoma (HCC); however, the relevance to clinical decision-making has been limited by the infrequency…
  • 2015 American Transplant Congress

    Validation of a Peripheral Blood Gene Expression Profile for SubClinical Acute Rejection in Kidney Transplant Recipients – Findings from the CTOT 08 Study

    J. Friedewald,1 S. Kurian,2 T. Gelbart,2 D. Salomon,2 M. Abecassis.1

    1Northwestern University, Chicago; 2Scripps Research Institute, La Jolla.

    Background: Sub-clinical acute rejection (SCAR) is histologic acute cellular rejection in the presence of a normal/stable serum creatinine, and is associated with worse graft survival.…
  • 2015 American Transplant Congress

    Non-Invasive Panel of MicroRNAs Predict Long-Term Outcomes Post-Kidney Transplantation

    J. Suh,1 D. Maluf,1 H. Cathro,2 R. Gehrau,1 I. McConnell,1 K. Brayman,1 C. Dumur,2 V. Mas.1

    1Surgery and Pathology, UVA, Charlottesville, VA; 2VCU, Richmond, VA.

    Background. Currently available methods for evaluating kidney graft function post-transplantation (KT) are either ineffective or inaccurate (e.g., serum creatinine) or highly invasive (e.g., biopsies). We…
  • 2015 American Transplant Congress

    Plasma 4β-Hydroxycholesterol Measurement as a Potential Biomarker for CYP3A5 Activity in Informing Tacrolimus Dosing

    T. Elnahhas,1,2 E. de Jonge,4 T. Lee,2 B. van Zelst,4 J. Popoola,3 R. Ramkhelawon,3 R. van Schaik,4 A. Johnston,1,2 I. MacPhee.3

    1Clinical Pharmacology, Queen Mary University of London, London, United Kingdom; 2Analytical Services International, St.George's University of London, London, United Kingdom; 3Institute of Medical and Biomedical Education-Renal Medicine, St.George's University of London, London, United Kingdom; 4Clinical Chemistry, Erasmus MC Rotterdam, Rotterdam, Netherlands.

    Background—Recently, 4β-hydroxycholesterol (4β-OHC) has been shown to be an endogenous marker of P450 3A activity in clinical practice (Diczfalusy et al, 2011). 4β-OHC concentration increases…
  • 2015 American Transplant Congress

    APOL1 High-Risk Genotype in African American Live Kidney Donors Is Not Associated With Post-Donation Development of Hypertension and Kidney Disease

    M. Doshi,1 M. Goggines,2 C. Winkler,3 J. Kopp.4

    1Wayne State University, Detroit, MI; 2Henry Ford Transplant Institute, Detroit, MI; 3NCI and Leidos, Frederick, MD; 4NIDDK, Bethseda, MD.

    African Americans (AA) with two apolipoprotein L1 (APOL1) risk alleles have more kidney disease than compared to those with one or zero risk alleles. A…
  • 2015 American Transplant Congress

    Correlation of Longitudinal Gene-Expression Profiling Score to Cytomegalovirus Infection: Results from the Outcomes AlloMap® Registry

    M. Kanwar,1 J. Yee,2 G. Ewald,3 S. Murali,1 J. Teuteberg.4

    1Allegheny Singer Research Institute, Pittsburgh, PA; 2CareDx, Inc., Brisbane, CA; 3Washington University, St. Louis, MO; 4University of Pittsburgh Medical Center, Pittsburgh, PA.

    Purpose: Cytomegalovirus (CMV) infection has been implicated in the pathogenesis of allograft rejection, which is reflected by high gene-expression profiling (GEP) scores. In the IMAGE…
  • 2015 American Transplant Congress

    Plasma Levels of Donor-Derived Cell-Free DNA Increase With Rejection and Often Decrease After Treatment in Organ Transplant Recipients

    M. Grskovic,1 J. Beausang,1 D. Hiller,1 R. Sit,1 B. Christie,1 J. Elechko,1 R. Woodward,1 J. Yee,1 J. Kobashigawa.2

    1CareDx, Inc, Brisbane, CA; 2Cedars-Sinai Medical Center, Los Angeles, CA.

    Purpose: Donor-derived cell-free DNA (dd-cfDNA) is a potential biomarker of acute cellular rejection (ACR) in organ transplant recipients. dd-cfDNA levels in longitudinal plasma samples from…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences